A team from MRC Unit The Gambia, visited collaborators at the Institute de Recherché en Sciences de la Santé in Burkina Faso as part of the PregnAnZI-2 project from July 23rd to July 27th. The visit aimed to discuss logistical and scientific aspects of the implementation of the large-multi country trial in Burkina Faso. The trial will evaluate the effect of administering an antibiotic, Azithromycin, during labour to reduce neonatal mortality with potential widespread impacts on maternal and neonatal infections.The visit was a vital aspect of ensuring homogenization of procedures during the set-up period of the large-multi country trial, which aims to recruit 12,500 women during labour, half of them in The Gambia and the other half in Burkina Faso. Members from the Disease Control and Elimination Theme (DCE) theme including Prof Umberto D’Alessandro (Unit Director and Trial co-investigator), Dr Anna Roca (Trial Chief Investigator), and Alyson Lush (Trial Project Manager), were hosted by Burkina investigators from the PregnAnZI-2 trial in Ouagadougou. The MRCG team later travelled to the research field station in Nanoro, situated in a rural area 60 kilometres from the capital, and were welcomed by local Principal Investigator (PI) Dr Halidou Tinto, a former PhD student of Prof Umberto D’Alessandro. During the stay, they visited the research centre in Nanoro, as well as four of the seven health facilities where the study will be conducted. The recruitment of study participants is expected to start in Burkina Faso in early November 2017 and will last for approximately three years.